VMP 39704511000001106

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Tamoxifen 20mg tablets
BNF code 0803041S0AAABAB
Virtual Therapeutic Moiety Tamoxifen
Date identifier became valid 26 May 2021
Previous product identifier 327313009
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Tamoxifen citrate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 373345002
Strength value numerator 20.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Tamoxifen 20mg tablets (A A H Pharmaceuticals Ltd)
Tamoxifen 20mg tablets (Accord-UK Ltd)
Tamoxifen 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Tamoxifen 20mg tablets (Genesis Pharmaceuticals Ltd)
Tamoxifen 20mg tablets (Medihealth (Northern) Ltd)
Tamoxifen 20mg tablets (Milpharm Ltd)
Tamoxifen 20mg tablets (Phoenix Healthcare Distribution Ltd)
Tamoxifen 20mg tablets (Relonchem Ltd)
Tamoxifen 20mg tablets (Tillomed Laboratories Ltd)
Tamoxifen 20mg tablets (Viatris UK Healthcare Ltd)
Tamoxifen 20mg tablets (Wockhardt UK Ltd)
Virtual Medicinal Product Packs
Tamoxifen 20mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback